U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

It may not be the mythical fountain of youth, but the strength of the body's immune system, or immune resilience, could hold ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

They're brightly colored, packed in enticing boxes and often marketed as healthy -- but many cereals today are actually less ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

CRISPR Therapeutics announced an agreement with Sirius Therapeutics to develop and commercialize small interfering RNA (siRNA ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...